Outlook Therapeutics Statistics
Total Valuation
OTLK has a market cap or net worth of $186.31 million. The enterprise value is $183.82 million.
| Market Cap | 186.31M |
| Enterprise Value | 183.82M |
Important Dates
The next estimated earnings date is Monday, August 12, 2024, before market open.
| Earnings Date | Aug 12, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
OTLK has 23.41 million shares outstanding. The number of shares has increased by 11.20% in one year.
| Shares Outstanding | 23.41M |
| Shares Change (YoY) | +11.20% |
| Shares Change (QoQ) | +9.66% |
| Owned by Insiders (%) | 36.22% |
| Owned by Institutions (%) | 33.26% |
| Float | 11.99M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | 2.85 |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | n/a |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.07
| Current Ratio | 1.07 |
| Quick Ratio | n/a |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -71.52 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -404.20% |
| Return on Capital (ROIC) | n/a |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$6.63M |
| Employee Count | 24 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, OTLK has paid $2,800 in taxes.
| Income Tax | 2,800 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -77.64% in the last 52 weeks. The beta is 0.72, so OTLK's price volatility has been lower than the market average.
| Beta (5Y) | 0.72 |
| 52-Week Price Change | -77.64% |
| 50-Day Moving Average | 7.62 |
| 200-Day Moving Average | 8.20 |
| Relative Strength Index (RSI) | 50.59 |
| Average Volume (20 Days) | 266,827 |
Short Selling Information
The latest short interest is 1.95 million, so 8.35% of the outstanding shares have been sold short.
| Short Interest | 1.95M |
| Short Previous Month | 1.65M |
| Short % of Shares Out | 8.35% |
| Short % of Float | 16.30% |
| Short Ratio (days to cover) | 7.53 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -59.86M |
| Pretax Income | -159.13M |
| Net Income | -159.13M |
| EBITDA | -156.86M |
| EBIT | -156.94M |
| Earnings Per Share (EPS) | -$11.41 |
Balance Sheet
The company has $47.23 million in cash and $44.75 million in debt, giving a net cash position of $2.48 million or $0.11 per share.
| Cash & Cash Equivalents | 47.23M |
| Total Debt | 44.75M |
| Net Cash | 2.48M |
| Net Cash Per Share | $0.11 |
| Equity (Book Value) | -134.24M |
| Book Value Per Share | -5.74 |
| Working Capital | 3.71M |
Cash Flow
| Operating Cash Flow | -58.26M |
| Capital Expenditures | n/a |
| Free Cash Flow | -58.26M |
| FCF Per Share | -$4.08 |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
OTLK does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -11.20% |
| Shareholder Yield | -11.20% |
| Earnings Yield | -85.41% |
| FCF Yield | -31.27% |
Analyst Forecast
The average price target for OTLK is $46.43, which is 483.29% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $46.43 |
| Price Target Difference | 483.29% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 9 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock Splits
The last stock split was on March 14, 2024. It was a reverse split with a ratio of 1:20.
| Last Split Date | Mar 14, 2024 |
| Split Type | Reverse |
| Split Ratio | 1:20 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 1 |